Session III: September 21, 2022
Increasing the Participation of African American Patients in Prostate Cancer Clinical Trials
African American (AA) men are poorly represented in prostate cancer clinical trials relative to their disease burden and proportional representation in the general population. There is an unquestioned need to increase the AA participation in prostate cancer clinical trials to ensure that trial results reflect how this population that is most impacted by prostate cancer, will respond to the diagnostic and therapeutic products being investigated. This session will examine issues contributing to the inadequate representation of AA patients in these trials, and approaches to increasing participation.
Registration and More Details to Follow